E245-0231 Screening compound: N-{3-[4-(4-methoxyphenyl)piperazin-1-yl]propyl}-3-oxo-3,4-dihydro-2H-1,4-benzoxazine-6-sulfonamide

E245-0231 Screening compound: N-{3-[4-(4-methoxyphenyl)piperazin-1-yl]propyl}-3-oxo-3,4-dihydro-2H-1,4-benzoxazine-6-sulfonamide
E245-0231 Screening compound: N-{3-[4-(4-methoxyphenyl)piperazin-1-yl]propyl}-3-oxo-3,4-dihydro-2H-1,4-benzoxazine-6-sulfonamide alternative view

Chemical Structure Depiction of ChemDiv screening compound E245-0231
N-{3-[4-(4-methoxyphenyl)piperazin-1-yl]propyl}-3-oxo-3,4-dihydro-2H-1,4-benzoxazine-6-sulfonamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

E245-0231

Molecular Formula

C22H28N4O5S (C22 H28 N4 O5 S)

Compound Name

N-{3-[4-(4-methoxyphenyl)piperazin-1-yl]propyl}-3-oxo-3,4-dihydro-2H-1,4-benzoxazine-6-sulfonamide

IUPAC name

N-{3-[4-(4-methoxyphenyl)piperazin-1-yl]propyl}-3-oxo-34-dihydro-2H-14-benzoxazine-6-sulfonamide

SMILES

COc(cc1)ccc1N1CCN(CCCNS(c(cc2)cc(N3)c2OCC3=O)(=O)=O)CC1

InChI

InChI=1S/C22H28N4O5S/c1-30-18-5-3-17(4-6-18)26-13-11-25(12-14-26)10-2-9-23-32(28,29)19-7-8-21-20(15-19)24-22(27)16-31-21/h3-8,15,23H,2,9-14,16H2,1H3,(H,24,27)

InChI Key

RTHNCORARMKINY-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD14852465

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

460.55

Hydrogen Bond Acceptors Count

10.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

8.00

Number of Nitrogen and Oxygen Atoms

9

Partition Coefficient, logP

1.819

Distribution Coefficient, logD

1.525

Water Solubility, LogSw

-2.71

Polar Surface Area

89.895

Acid Dissociation Constant (pKa)

10.71

Base Dissociation Constant (pKb)

7.38

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

40.90

E245-0231 in Drug Discovery

Included in Screening Libraries

3D-Pharmacophore Based Diversity Library (49813 compounds)

GPCR Targeted Library (31838 compounds)

Glucocorticoid receptors Library (4806 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
  • Cancer
  • Nervous system
  • Hemic and lymphatic
  • Congenital
  • Metabolic
  • Endocrine
Targets:
  • GPCR
  • Nuclear receptors
Mechanism of action:
  • Receptor's ligands
  • Receptor's ligands

References: we are preparing a list of scientific research reports with E245-0231 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound E245-0231?
Check Price and Availability of E245-0231, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of E245-0231 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for E245-0231
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for E245-0231
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of E245-0231 available by request